“Enabling the Data Sharing Ecosystem”
Vivli’s 2022 Annual Meeting was held on Wednesday, November 2nd, 2022, 9:00am – 12:00pm EST / 2:00 – 5:00pm CET / 10:00pm – 1:00am JST. This meeting served as a chance to allow Vivli data contributors, key collaborators and funders to discuss data sharing and its importance for furthering scientific discoveries.
View the Recording
Agenda
Welcome remarks
Vivli Update for 2022, Rebecca Li, Executive Director, Vivli
Sharing COVID-19 Clinical Trial Data on Vivli
Reflecting on best practices and current experience
- Julie Holtzople, Senior Director Clinical Transparency and Data Sharing, AstraZeneca
- Steve Kern, Interim CEO, Global Health Labs
- Ben Rotz, Associate Vice President – Global Medical Policy Strategy and Operations, Lilly
- David Leventhal, Enterprise Clinical Trial Data Sharing Lead, Pfizer
- Rebecca Sudlow, Global Lead Patient Level Data Sharing, Roche
Q&A
NIH Data Sharing Policy Changes in 2023
- Dr. Susan Gregurick, Associate Director for Data Science and Director of the Office of Data Science Strategy (ODSS), NIH
Q&A
Data Challenges
Spotlighting data challenges Vivli is embarking on with key partners in 2022-2023
- Deniz Dalton, Program Officer, The Leona M. and Harry B. Helmsley Charitable Trust, presenting “Moving Type 1 Diabetes and Exercise Data to Solutions”
- Tetsuyuki Maruyama, Executive Director, Alzheimer’s Disease Data Initiative (ADDI), presenting “ADDI/Vivli Data Challenge in Alzheimer’s Disease”
Next Steps and Discussion